![Christopher Silber](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Christopher Silber first degree
Entity | Entity type | Industry | |
---|---|---|---|
OVATION Pharmaceuticals, Inc.
![]() OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL.
13
| Extinct | Pharmaceuticals: Major | 13 |
Public Company | Pharmaceuticals: Major | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Silber via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Paragon Biosciences Skyline Capital LLC
![]() Paragon Biosciences Skyline Capital LLC Pharmaceuticals: MajorHealth Technology Paragon Biosciences Skyline Capital LLC engages in the provision of pharmaceutical services. The company is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Director/Board Member President Director/Board Member | |
CIRC Biosciences, Inc.
![]() CIRC Biosciences, Inc. BiotechnologyHealth Technology CIRC Biosciences, Inc. is a privately held cell therapy company that focuses on developing treatments for serious diseases with high unmet needs. The company is based in Dallas, TX. The company's initial focus is on the eye. The company was founded by Jeffrey S. Aronin. | Biotechnology | Founder President Director/Board Member | |
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Biotechnology | Founder Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
DePaul University | College/University | Masters Business Admin Undergraduate Degree | |
Paragon Biosciences Qlarity Capital, Inc.
![]() Paragon Biosciences Qlarity Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Qlarity Capital, Inc. provides pharmaceutical services. The company was founded in 2018 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Director/Board Member President | |
Paragon Biosciences Emalex Capital, Inc.
![]() Paragon Biosciences Emalex Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Emalex Capital, Inc. provides pharmaceuticals services. The company is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Director/Board Member President | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Colorado | College/University | Doctorate Degree Undergraduate Degree | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Lundbeck, Inc.
![]() Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | Chief Executive Officer President | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Parke, Davis & Co. LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Alcon Laboratories, Inc.
![]() Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal | |
SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Veridex LLC
![]() Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Medical Specialties | Sales & Marketing | |
St. Joseph's University | College/University | Masters Business Admin | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
MEDIVATION INC | Pharmaceuticals: Major | Chief Executive Officer | |
UROGEN PHARMA LTD. | Biotechnology | Chief Executive Officer | |
ALLOGENE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Louisiana at Lafayette | College/University | Undergraduate Degree | |
UroGen Pharma, Inc. | Biotechnology | Chief Executive Officer | |
New Leaf Venture Partners LLC
![]() New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group. | Investment Managers | Private Equity Analyst | |
Florida State University | College/University | Undergraduate Degree | |
University of Lagos | College/University | Doctorate Degree | |
DISCOVER FINANCIAL SERVICES | Finance/Rental/Leasing | Director/Board Member | |
Millennium Pharmaceuticals, Inc.
![]() Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Chroma Medicine, Inc.
![]() Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member | |
Pierce Biotechnology, Inc.
![]() Pierce Biotechnology, Inc. BiotechnologyHealth Technology Part of Thermo Fisher Scientific, Inc., Pierce Biotechnology, Inc. is a company that offers a range of innovative, high-quality products for protein biology research. The company is based in Rockford, IL. The company's products include Pierce antibodies, SuperSignal chemiluminescent substrates, Pierce BCA protein assays, and other research tools and reagents. | Biotechnology | Corporate Officer/Principal | |
Promega Corp.
![]() Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Biotechnology | Corporate Officer/Principal | |
SHATTUCK LABS, INC. | Biotechnology | Chairman | |
Verseau Therapeutics, Inc.
![]() Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Chairman | |
AURA BIOSCIENCES, INC. | Biotechnology | Chairman | |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst | |
Corbus Pharmaceuticals, Inc.
![]() Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corbus Pharmaceuticals, Inc. is engaged in biotechnology services. The company is headquartered in Norwood, MA. | Pharmaceuticals: Major | Director/Board Member | |
Carrick Therapeutics UK Ltd.
![]() Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Carrick Therapeutics Ltd., Carrick Therapeutics UK Ltd. is a clinical-stage biopharmaceutical company based in Oxford, UK. Carrick Therapeutics translates in-house and in-licensed assets to target the most aggressive and resistant forms of cancer, working in combination with existing oncology drugs to address unmet patient needs. The British company focuses on developing innovative therapies to improve patient outcomes in oncological therapy. The company's therapies have potential in advanced breast, prostate, and ovarian cancers, with further potential in pancreatic and Ewing's sarcoma. Timothy R. Pearson has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Chairman | |
Droia Ventures | Corporate Officer/Principal |
Statistics
International
United States | 47 |
United Kingdom | 3 |
Belgium | 2 |
Sectoral
Health Technology | 35 |
Consumer Services | 8 |
Finance | 5 |
Commercial Services | 3 |
Operational
Director/Board Member | 93 |
Corporate Officer/Principal | 76 |
Chairman | 31 |
Chief Executive Officer | 29 |
President | 26 |
Most connected contacts
Insiders | |
---|---|
George Golumbeski | 36 |
Jeffrey Aronin | 35 |
Howard H. Pien | 27 |
Sean Nolan | 18 |
Thomas Anderson | 17 |
Elizabeth Barrett | 14 |
Patrick Morris | 12 |
Lance D. Williams | 10 |
Timothy Cunniff | 10 |
Micah Mackison | 9 |
Paul Cox | 9 |
Asha Nayak | 9 |
Xiao Bing Li | 9 |
Bryan Stuart | 9 |
Sally Benjamin Young | 8 |
- Stock Market
- Insiders
- Christopher Silber
- Company connections